Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications

Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 13; no. 9; p. 1452
Main Authors Ji, Hao, Peng, Renyi, Jin, Libo, Ma, Jiahui, Yang, Qinsi, Sun, Da, Wu, Wei
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 11.09.2021
MDPI
Subjects
Amino acids
Atherosclerosis
Bioavailability
Cardiovascular disease
Drug dosages
imaging
Inflammation
Lipids
Metabolism
Metabolites
Mortality
nano-formulations
Nanoparticles
Physiology
Polyethylene glycol
polymer
Polypeptides
reactive oxygen species
Review
Selenium
atherosclerosis
polymer
nano-formulations
imaging
reactive oxygen species
Online AccessGet full text

Cover

More Information
Summary:Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics13091452